Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ).
Beximco Pharmaceuticals Limited has announced a change in its board of directors, with Mr. Mohammed Ebtadul Islam replacing Ms. Quamrun Naher Ahmed as a Non-Executive Director. Mr. Islam brings extensive experience in finance and management from his long career at Bangladesh Bank and his current role as an independent director at IFIC Bank PLC. This appointment is expected to aid Beximco Pharma in continuing its focus on business growth and enhancing shareholder value.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited, established in 1976, is a leading manufacturer and exporter of generic medicines based in Bangladesh. The company offers a broad portfolio of products, including tablets, capsules, liquids, and injectables, and is engaged in contract manufacturing for multinational and global generic pharmaceutical companies. Its state-of-the-art facilities are certified by global regulatory authorities and it operates in over 50 countries with more than 6000 employees.
YTD Price Performance: -1.28%
Average Trading Volume: 50,401
Technical Sentiment Consensus Rating: Hold
For detailed information about BXP stock, go to TipRanks’ Stock Analysis page.
